nadolol

Generic: nadolol

Labeler: amneal pharmaceuticals ny llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name nadolol
Generic Name nadolol
Labeler amneal pharmaceuticals ny llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

nadolol 40 mg/1

Manufacturer
Amneal Pharmaceuticals NY LLC

Identifiers & Regulatory

Product NDC 69238-1124
Product ID 69238-1124_c1092e52-cd19-48ff-8c50-476c5243667a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208832
Listing Expiration 2026-12-31
Marketing Start 2017-06-02

Pharmacologic Class

Established (EPC)
beta-adrenergic blocker [epc]
Mechanism of Action
adrenergic beta-antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 692381124
Hyphenated Format 69238-1124

Supplemental Identifiers

RxCUI
198006 198007 198008
UPC
0369238112337 0369238112535 0369238112436
UNII
FEN504330V
NUI
N0000000161 N0000175556

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name nadolol (source: ndc)
Generic Name nadolol (source: ndc)
Application Number ANDA208832 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 40 mg/1
source: ndc
Packaging
  • 1000 TABLET in 1 BOTTLE (69238-1124-1)
  • 30 TABLET in 1 BOTTLE (69238-1124-3)
  • 90 TABLET in 1 BOTTLE (69238-1124-9)
source: ndc

Packages (3)

Ingredients (1)

nadolol (40 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c1092e52-cd19-48ff-8c50-476c5243667a", "openfda": {"nui": ["N0000000161", "N0000175556"], "upc": ["0369238112337", "0369238112535", "0369238112436"], "unii": ["FEN504330V"], "rxcui": ["198006", "198007", "198008"], "spl_set_id": ["e2e24b14-0169-4028-828a-894ad3c2ba55"], "pharm_class_epc": ["beta-Adrenergic Blocker [EPC]"], "pharm_class_moa": ["Adrenergic beta-Antagonists [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (69238-1124-1)", "package_ndc": "69238-1124-1", "marketing_start_date": "20170602"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (69238-1124-3)", "package_ndc": "69238-1124-3", "marketing_start_date": "20170602"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (69238-1124-9)", "package_ndc": "69238-1124-9", "marketing_start_date": "20170602"}], "brand_name": "Nadolol", "product_id": "69238-1124_c1092e52-cd19-48ff-8c50-476c5243667a", "dosage_form": "TABLET", "pharm_class": ["Adrenergic beta-Antagonists [MoA]", "beta-Adrenergic Blocker [EPC]"], "product_ndc": "69238-1124", "generic_name": "Nadolol", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nadolol", "active_ingredients": [{"name": "NADOLOL", "strength": "40 mg/1"}], "application_number": "ANDA208832", "marketing_category": "ANDA", "marketing_start_date": "20170602", "listing_expiration_date": "20261231"}